FDA Issues Guidance on Microbiological Contamination After Many Adverse Events

Due in part to a high number of adverse events and recalls associated with contaminated products, the FDA has issued a 21-page draft guidance to help manufacturers control microbiological contamination of their nonsterile drugs (NSDs).
Source: Drug GMP Report